Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
9.04
0.00 (0.00%)
At close: Oct 9, 2026, 4:00 PM EDT
9.01
-0.03 (-0.33%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Alpha Cognition Revenue
Alpha Cognition had revenue of $6.09M in the quarter ending June 30, 2026, with 267.56% growth. This brings the company's revenue in the last twelve months to $15.26M, up 232.74% year-over-year. In the year 2025, Alpha Cognition had annual revenue of $10.22M. That makes Alpha Cognition the 35,279th largest company in the world by revenue and 4,656th in the United States.
Revenue (ttm)
$15.26M
Revenue Growth
+232.74%
P/S Ratio
12.90
Revenue / Employee
$214,940
Employees
71
Market Cap
196.87M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.22M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 74.00M |
| Alector | 13.86M |
| Adagene | 9.29M |
| Whitehawk Therapeutics | 7.15M |
| Entrada Therapeutics | 4.69M |
| Oramed Pharmaceuticals | 2.00M |
| Cartesian Therapeutics | 1.48M |
ACOG News
- 3 days ago - Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress - Business Wire
- 7 days ago - Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 8 days ago - Alpha Cognition announces CONVERGE RWE on ZUNVEYL - TheFly
- 8 days ago - Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care - Business Wire
- 18 days ago - Alpha Cognition management to meet virtually with B. Riley - TheFly
- 7 weeks ago - Alpha Cognition initiated with a Buy at B. Riley - TheFly
- 7 weeks ago - Alpha Cognition initiated with a Buy at B. Riley - TheFly
- 7 weeks ago - Alpha Cognition price target raised to $20 from $18 at H.C. Wainwright - TheFly